Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pancreatic cancer.

R M Beazley, I Cohn

    CA: a Cancer Journal for Clinicians
    |November 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Increased funding has spurred research into pancreatic carcinoma, aiding in identifying at-risk populations and improving early diagnosis through advanced techniques and tumor markers for better treatment outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Dyschondroplasia.

    Annals of surgery·2010
    Same author

    Dyschondroplasia.

    Transactions of the Southern Surgical Association. Southern Surgical Association (U.S.)·2010
    Same author

    Tolerability, pharmacokinetics and concentration-dependent hemodynamic effects of oral CF101, an A3 adenosine receptor agonist, in healthy young men.

    International journal of clinical pharmacology and therapeutics·2004
    Same author

    Endowed chairs named for surgeons.

    Journal of the American College of Surgeons·2000
    Same author

    Early work in lymphatic mapping.

    Surgery·2000
    Same author

    Cathepsin B activity and protein levels in thyroid carcinoma, Graves' disease, and multinodular goiters.

    Thyroid : official journal of the American Thyroid Association·1999
    Same journal

    Extranodal natural killer/T-cell lymphoma: From fatal to curable.

    CA: a cancer journal for clinicians·2026
    Same journal

    Data support longer recurrence-free survival with nivolumab than with ipilimumab for stage III or IV melanoma.

    CA: a cancer journal for clinicians·2026
    Same journal

    Study finds ovarian cancer survivors who are BRCA carriers have a relatively low risk of breast cancer.

    CA: a cancer journal for clinicians·2026
    Same journal

    Radiation therapy, cytogenetic prognostication, novel systemic chemotherapy, and patient perspective in an adult with choroidal melanoma.

    CA: a cancer journal for clinicians·2026
    Same journal

    Systemic amyloid light-chain amyloidosis beyond ANDROMEDA: Diagnostic challenges and therapeutic updates.

    CA: a cancer journal for clinicians·2026
    Same journal

    Correction to "Integrating multimodal management and molecular profiling in a patient with BRAF V600E-positive melanoma and brain metastases".

    CA: a cancer journal for clinicians·2026
    See all related articles

    Area of Science:

    • Oncology
    • Epidemiology
    • Diagnostic Medicine

    Background:

    • Pancreatic carcinoma research has seen significant funding increases recently.
    • Epidemiologic data collection for pancreatic cancer is expanding.
    • Early detection of pancreatic cancer remains a critical challenge.

    Purpose of the Study:

    • To review advancements in pancreatic carcinoma research.
    • To highlight the potential for identifying at-risk populations.
    • To discuss the role of diagnostic techniques and tumor markers in early disease detection.

    Main Methods:

    • Review of recent epidemiologic studies on pancreatic cancer.
    • Analysis of current diagnostic capabilities for pancreatic lesions.
    • Assessment of developments in pancreatic cancer tumor markers.

    Related Experiment Videos

    Main Results:

    • Increased investigative attention and funding for pancreatic carcinoma.
    • Accumulation of substantial epidemiologic data.
    • Improved diagnostic techniques for detecting small pancreatic lesions.
    • Advancements in tumor marker technology.

    Conclusions:

    • Early detection of pancreatic cancer is crucial for potential cure.
    • Screening the at-risk population for early pancreatic disease is becoming feasible.
    • Continued research and technological development are vital for improving pancreatic cancer outcomes.